Company / PP&E per Share
Kiniksa Pharmaceuticals International, plc PP&E per Share History
FY2017-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest PP&E per Share
$0.03
FY2025
5-year range
$0.01 / $0.05
FY2021-FY2025
Trend
+187.4%
vs FY2024
Sector context
#137 of 191
Health Care
What the data says
At $0.03, Kiniksa Pharmaceuticals International, plc's pp&e per share ranks #137 of 191 in the Health Care sector. PP&E per Share returned to growth in FY2025 after 6 years of decline, reaching $0.03.
Based on SEC 10-K filings.
0.03 in FY2025 with a 5-year CAGR of -16.2%.
Improved from $0.01 to $0.03 over the past 2 years.
Health Care sector context is included.
PP&E per Share over time
Growth rates
- 3-Year CAGR
- +0.3%
- 5-Year CAGR
- -16.2%
- 10-Year CAGR
- -
Sector benchmark
#137 of 191 in Health CareTop 72% of 191This company $0.03 Sector average $18.90
▼
-99.9% below sector average
Key checks
Key Insights
- In FY2025, pp&e per share increased 187.4% year-over-year.
- Ranks #137 out of 191 companies in the Health Care sector.
- Peak pp&e per share was recorded in FY2018.
- Lowest pp&e per share in the period was in FY2024.
Company context
Key Data Points
- Negative profit margin: -10.2%
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | PP&E per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $0.03 | +187.4% |
| FY2024 | $0.01 | -12.2% |
| FY2023 | $0.01 | -60.1% |
| FY2022 | $0.03 | -48.9% |
| FY2021 | $0.05 | -20.0% |
| FY2020 | $0.07 | -44.7% |
| FY2019 | $0.12 | -45.0% |
| FY2018 | $0.22 | +211.4% |
| FY2017 | $0.07 | - |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026